mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.4 |